Business Description
Suven Pharmaceuticals Ltd
ISIN : INE03QK01018
Compare
Compare
Traded in other countries / regions
SUVENPHAR.India IPO Date
2020-03-09Description
Suven Pharmaceuticals Ltd is engaged in the development and manufacturing of Intermediates, Active Pharmaceutical Ingredients (API), specialty chemicals and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology and chemical companies. The company has single operating segment that is Pharmaceuticals Manufacturing & Services and its geographical segments include India; the USA; Europe and the Rest of the World. The company derives a majority of revenue from the Europe segment.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.06 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.09 | |||||
| Interest Coverage | 87.51 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 57.53 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.5 | |||||
| 3-Year EBITDA Growth Rate | 11 | |||||
| 3-Year EPS without NRI Growth Rate | 8.6 | |||||
| 3-Year FCF Growth Rate | -18.4 | |||||
| 3-Year Book Growth Rate | 27.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.47 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.19 | |||||
| 9-Day RSI | 63.87 | |||||
| 14-Day RSI | 58.59 | |||||
| 6-1 Month Momentum % | 19.33 | |||||
| 12-1 Month Momentum % | 41.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.4 | |||||
| Quick Ratio | 7.99 | |||||
| Cash Ratio | 6.35 | |||||
| Days Inventory | 236.85 | |||||
| Days Sales Outstanding | 38.32 | |||||
| Days Payable | 50.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.2 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.32 | |||||
| Operating Margin % | 40.13 | |||||
| Net Margin % | 32.54 | |||||
| FCF Margin % | 14.49 | |||||
| ROE % | 21.51 | |||||
| ROA % | 18.89 | |||||
| ROIC % | 24.99 | |||||
| ROC (Joel Greenblatt) % | 44.5 | |||||
| ROCE % | 28.11 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 46.04 | |||||
| PE Ratio without NRI | 47.53 | |||||
| Price-to-Owner-Earnings | 47.68 | |||||
| PS Ratio | 14.98 | |||||
| PB Ratio | 8.83 | |||||
| Price-to-Tangible-Book | 9.12 | |||||
| Price-to-Free-Cash-Flow | 103.47 | |||||
| Price-to-Operating-Cash-Flow | 37.89 | |||||
| EV-to-EBIT | 32.93 | |||||
| EV-to-EBITDA | 30.02 | |||||
| EV-to-Forward-EBITDA | 18.65 | |||||
| EV-to-Revenue | 14.63 | |||||
| EV-to-Forward-Revenue | 7.89 | |||||
| EV-to-FCF | 100.96 | |||||
| Earnings Yield (Greenblatt) % | 3.04 | |||||
| FCF Yield % | 0.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Suven Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 11,397.356 | ||
| EPS (TTM) (₹) | 14.58 | ||
| Beta | 0.8 | ||
| Volatility % | 22.36 | ||
| 14-Day RSI | 58.59 | ||
| 14-Day ATR (₹) | 21.046961 | ||
| 20-Day SMA (₹) | 643.5175 | ||
| 12-1 Month Momentum % | 41.04 | ||
| 52-Week Range (₹) | 427.05 - 767 | ||
| Shares Outstanding (Mil) | 254.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Suven Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Suven Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Suven Pharmaceuticals Ltd Frequently Asked Questions
What is Suven Pharmaceuticals Ltd(BOM:543064)'s stock price today?
The current price of BOM:543064 is ₹671.20. The 52 week high of BOM:543064 is ₹767.00 and 52 week low is ₹427.05.
When is next earnings date of Suven Pharmaceuticals Ltd(BOM:543064)?
The next earnings date of Suven Pharmaceuticals Ltd(BOM:543064) is .
Does Suven Pharmaceuticals Ltd(BOM:543064) pay dividends? If so, how much?
Suven Pharmaceuticals Ltd(BOM:543064) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers